Clinical Trial: Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment in Asians
Brief Summary:
Study centre and address
King Chulalongkorn Memorial Hospital
Primary objective
To compare the efficacy and the safety of methylene blue-mediated photodynamic therapy and 5% amorolfine nail lacquer for toenail onychomycosis in Asians
Detailed Summary:
• Research Design
Randomized, single-blind clinical trial
• Research Methodology
Target population
- 42 Patients, aged between 18-90 years old, with distal and lateral subungual toenail onychomycosis diagnosed clinically and mycologically
-
Patients were recruited from Dermatology clinic, King Chulalongkorn Memorial Hospital
-
Exclusion criteria
- Those with nail changes because of skin disease or associated systemic diseases
- Those who had previously used anti-fungal medications within 3 months for systemic and 1 month for topical therapy.
-
Methods
- Patients will be informed of the details of the study including predicted possible adverse events due to the treatments and primary aids.
- They will be included in stratified randomly by poor prognostic factors, then divided into two groups (A: methylene blue-mediated photodynamic therapy (MB-PDT) and B: 5% Amorolfine Nail Lacquer by block randomization of size 4 and 6.
- For 24 weeks,
-
-
Group A
- The use
Sponsor: Chulalongkorn University
Current Primary Outcome: Onychomycosis severity index (OSI) [ Time Frame: Change from baseline Onychomycosis severity index at every 2 weeks through the MB-PDT treatment completion, 12 weeks; then change from baseline Onychomycosis severity index at every 8 weeks through the study completion, an average of 18 months. ]
Photographs taken by using a dermoscope were evaluated by two independent dermatologists.
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Chulalongkorn University
Dates:
Date Received: February 20, 2017
Date Started: June 1, 2017
Date Completion: January 31, 2019
Last Updated: March 27, 2017
Last Verified: February 2017
- The use